Skip to main content
SpringerLink
Log in

Bevacizumab/docetaxel/paclitaxel

Nasal septum perforation (first report with paclitaxel): 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Mailliez A, Baldini C, Van JT, Servent V, Mallet Y, Bonneterre J.Nasal septum perforation: A side effect of bevacizumab chemotherapy in breast cancer patients. British Journal of Cancer 103: 772-775, 7 Sep 2010. Available from: URL: http://dx.doi.org/10.1038/sj.bjc.6605828 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/docetaxel/paclitaxel. React. Wkly. 1323, 11–12 (2010). https://doi.org/10.2165/00128415-201013230-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013230-00032

Keywords

Search

Navigation